natgillin/translations-raw huggingface dataset:
The draft assessment report, the additional report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and finalised on 17 June 2011 in the format of the Commission review report for terbuthylazine.
Države članice in Komisija so osnutek poročila o oceni, dodatno poročilo in sklep Agencije pregledale v Stalnem odboru za prehranjevalno verigo in zdravje živali ter končno različico pripravile 17. junija 2011 v obliki poročila Komisije o pregledu terbutilazina.
It has appeared from the various examinations made that plant protection products containing terbuthylazine may be expected to satisfy, in general, the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC, in particular as regards the uses which were examined and detailed in the Commission review report.
Različne preiskave so pokazale, da se za fitofarmacevtska sredstva, ki vsebujejo terbutilazin, lahko pričakuje, da bodo na splošno izpolnjevala zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS, zlasti v zvezi z uporabami, ki so bile proučene in podrobno navedene v poročilu Komisije o pregledu.
It is therefore appropriate to approve terbuthylazine in accordance with Regulation (EC) No 1107/2009.
Zato je primerno, da se terbutilazin v skladu z Uredbo (ES) št. 1107/2009 odobri.
Without prejudice to the conclusion that terbuthylazine should be approved, it is, in particular, appropriate to require further confirmatory information.
Brez poseganja v sklep, da je treba terbutilazin odobriti, je še zlasti primerno zahtevati dodatne podatke potrditvene narave.
Member States should be allowed a period of six months after approval to review authorisations of plant protection products containing terbuthylazine.
Državam članicam je treba po odobritvi omogočiti šestmesečno obdobje, da pregledajo registracije fitofarmacevtskih sredstev, ki vsebujejo terbutilazin.
The active substance terbuthylazine, as specified in Annex I, is approved subject to the conditions laid down in that Annex.
Aktivna snov terbutilazin, kot je opredeljena v Prilogi I, je odobrena v skladu s pogoji iz navedene priloge.
Member States shall in accordance with Regulation (EC) No 1107/2009, where necessary, amend or withdraw existing authorisations for plant protection products containing terbuthylazine as an active substance by 30 June 2012.
Države članice v skladu z Uredbo (ES) št. 1107/2009 do 30. junija 2012 po potrebi spremenijo ali prekličejo veljavne registracije fitofarmacevtskih sredstev, ki vsebujejo terbutilazin kot aktivno snov.
By way of derogation from paragraph 1, for each authorised plant protection product containing terbuthylazine as either the only active substance or as one of several active substances all of which were listed in the Annex to Implementing Regulation (EU) No 540/2011 by 31 December 2011 at the latest, Member States shall re-evaluate the product in accordance with the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, on the basis of a dossier satisfying the requirements of Annex III to Directive 91/414/EEC and taking into account Part B of the column on specific provisions of Annex I to this Regulation.
Z odstopanjem od odstavka 1 države članice znova ocenijo vsako registrirano fitofarmacevtsko sredstvo, ki vsebuje terbutilazin kot edino aktivno snov ali kot eno od več aktivnih snovi, vključenih v Prilogo k Izvedbeni uredbi (EU) št. 540/2011, in najpozneje do 31. decembra 2011 v skladu z enotnimi načeli iz člena 29(6) Uredbe (ES) št. 1107/2009 na podlagi dokumentacije, ki izpolnjuje zahteve iz Priloge III k Direktivi 91/414/EGS, in ob upoštevanju dela B stolpca o posebnih določbah Priloge I k tej uredbi ponovno ocenijo sredstvo.
in the case of a product containing terbuthylazine as the only active substance, where necessary, amend or withdraw the authorisation by 31 December 2015 at the latest; or
če sredstvo vsebuje terbutilazin kot edino aktivno snov, najpozneje do 31. decembra 2015 po potrebi spremenijo ali prekličejo registracijo, ali
in the case of a product containing terbuthylazine as one of several active substances, where necessary, amend or withdraw the authorisation by 31 December 2015 or by the date fixed for such an amendment or withdrawal in the respective act or acts which added the relevant substance or substances to Annex I to Directive 91/414/EEC or approved that substance or substances, whichever is the latest.
če sredstvo vsebuje terbutilazin kot eno od več aktivnih snovi, registracijo po potrebi spremenijo ali prekličejo najpozneje do 31. decembra 2015 ali do datuma, določenega za tako spremembo ali preklic v ustreznih aktih, s katerimi so bile zadevne snovi dodane v Prilogo I k Direktivi 91/414/EGS oziroma s katerimi so bile zadevne snovi odobrene, pri čemer se upošteva poznejši datum.
The line concerning terbuthylazine in the Annex to Decision 2008/934/EC is deleted.
V Prilogi k Odločbi 2008/934/ES se črta vrstica o terbutilazinu.
European Food Safety Authority, Conclusion on the peer review of the pesticide risk assessment of the active substance terbuthylazine.
[8] Evropska agencija za varnost hrane; Sklep o strokovnem pregledu ocene tveganja pesticidov za aktivno snov terbutilazin.
EFSA Journal 2011; 9(1):1969 [133 pp.], doi:10.2903/j.efsa.2010.1969.
EFSA Journal 2011;9(1):1969. [133 str.]. doi:10.2903/j.efsa.2010.1969.
Terbuthylazine
terbutilazin
CAS No 5915-41-3
št. CAS 5915-41-3
CIPAC No 234
št. CIPAC 234
Propazine not more than 10 g/kg
propazin ne več kot 10 g/kg
Atrazine not more than 1 g/kg
atrazin ne več kot 1 g/kg
Simazine not more than 30 g/kg
simazin ne več kot 30 g/kg
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on terbuthylazine, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 17 June 2011 shall be taken into account.
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o pregledu terbutilazina in zlasti dodatka I in II h končni različici poročila, ki jo je Stalni odbor za prehranjevalno verigo in zdravje živali pripravil 17. junija 2011.
the risk to mammals and earthworms.
tveganje za sesalce in deževnike.
Conditions of use shall include risk mitigation measures and the obligation to carry out monitoring programmes to verify potential groundwater contamination in vulnerable zones, where appropriate.
Pogoji uporabe vključujejo ukrepe za zmanjšanje tveganja in obveznost za izvajanje programov spremljanja, da se po potrebi preveri morebitno onesnaženje podtalnice na občutljivih območjih.
groundwater exposure assessment for the unidentified metabolites LM1, LM2, LM3, LM4, LM5 and LM6;
oceni izpostavljenosti podtalnice neopredeljenim metabolitom LM1, LM2, LM3, LM4, LM5 in LM6;
the relevance of the metabolites MT1 (N-tert-butyl-6-chloro-1,3,5-triazine-2,4-diamine), MT 13 (4-(tert-butylamino)-6-(ethylamino)-1,3,5-triazin-2-ol or 6-hydroxy-N2-ethyl-N4-tert-butyl-1,3,5-triazine-2,4-diamine), MT14 (4-amino-6-(tert-butylamino)-1,3,5-triazin-2-ol or N-tert-butyl-6-hydroxy-1,3,5-triazine-2,4-diamine), and of the unidentified metabolites LM1, LM2, LM3, LM4, LM5 and LM6 with respect to cancer, if terbuthylazine is classified under Regulation (EC) No 1272/2008 as ‘suspected of causing cancer’.
relevantnosti metabolitov MT1 (N-terc-butil-6-kloro-1,3,5-triazin-2,4-diamin), MT 13 (4-(terc-butilamino)-6-(etilamino)-1,3,5-triazin-2-ol ali 6-hidroksi -N2-etil-N4- terc-butil-1,3,5-triazin-2,4-diamin), MT14 (4-amino-6-(terc-butilamino)-1,3,5-triazin-2-ol or N-terc-butil-6-hidroksi-1,3,5-triazin-2,4-diamin), ter neopredeljenih metabolitov LM1, LM2, LM3, LM4, LM5 in LM6 glede raka, če je terbutilazin v Uredbi (ES) št. 1272/2008 razvrščen v „sum povzročitve raka“.
The applicant shall submit to the Commission, the Member States and the Authority the information set out in points (1) and (2) by 30 June 2012, the information set out in point (3) by 30 June 2013 and the information set out in point (4) within six months from the notification of the classification decision concerning that substance.
Vlagatelj Komisiji, državam članicam in Agenciji predloži informacije iz točk 1 in 2 do 30. junija 2012, informacije iz točke 3 do 30. junija 2013, informacije iz točke 4 pa v šestih mesecih od obvestila o odločitvi o razvrstitvi navedene snovi.
the specification of the technical material, as commercially manufactured, by appropriate analytical data, including information on the relevance of the impurities;
specifikacijah tehničnega materiala v tržni proizvodnji z ustreznimi analitskimi podatki, vključno z informacijami o pomembnosti nečistoč;
the relevance of the metabolites MT1 (N-tert-butyl-6-chloro-1,3,5-triazine-2,4-diamine), MT 13 (4-(tert-butylamino)-6-(ethylamino)-1,3,5-triazin-2-ol or 6-hydroxy-N2-ethyl-N4-tert-butyl-1,3,5-triazine-2,4-diamine), MT14 (4-amino-6-(tert-butylamino)-1,3,5-triazin-2-ol or N-tert-butyl-6-hydroxy-1,3,5-triazine-2,4-diamine), and of the unidentified metabolites LM1, LM2, LM3, LM4, LM5 and LM6 with respect to cancer, if terbuthylazine is classified under Regulation (EC) No 1272/2008 as “suspected of causing cancer”.
relevantnosti metabolitov MT1 (N-terc-butil-6-kloro-1,3,5-triazin-2,4-diamin), MT 13 (4-(terc-butilamino)-6-(etilamino)-1,3,5-triazin-2-ol ali 6-hidroksi -N2-etil-N4- terc-butil-1,3,5-triazin-2,4-diamin), MT14 (4-amino-6-(terc-butilamino)-1,3,5-triazin-2-ol ali N-terc-butil-6-hidroksi-1,3,5-triazin-2,4-diamin), ter neopredeljenih metabolitov LM1, LM2, LM3, LM4, LM5 in LM6 glede raka, če je terbutilazin v Uredbi (ES) št. 1272/2008 razvrščen v ,sum povzročitve raka.
The applicant shall submit to the Commission, the Member States and the Authority the information set out in points (1) and (2) by 30 June 2012, the information set out in point (3) by 30 June 2013 and the information set out in point (4) within six months from the notification of the classification decision concerning that substance.’
Vlagatelj Komisiji, državam članicam in Agenciji predloži informacije iz točk 1 in 2 do 30. junija 2012, informacije iz točke 3 do 30. junija 2013, informacije iz točke 4 pa v šestih mesecih od obvestila o odločitvi o razvrstitvi navedene snovi.“
Decision 2008/934/EC provides for the non-inclusion of terbuthylazine and the withdrawal of authorisations for plants protection products containing that substance by 31 December 2011.
Odločba 2008/934/ES določa nevključitev terbutilazina in preklic registracije fitofarmacevtskih sredstev, ki vsebujejo navedeno snov, do 31. decembra 2011.
It is necessary to delete the line concerning terbuthylazine in the Annex to that Decision.
V Prilogi k navedeni odločbi je treba črtati vrstico o terbutilazinu.
Commission Regulation (EU) No 821/2011
Uredba Komisije (EU) št. 821/2011
imposing a provisional anti-dumping duty on imports of vinyl acetate originating in the United States of America
o uvedbi začasne protidampinške dajatve na uvoz vinilacetata s poreklom iz Združenih držav Amerike
Having regard to the Treaty on the Functioning of the European Union (the 'Union'),
ob upoštevanju Pogodbe o delovanju Evropske unije („Unija“),
Having regard to Council Regulation (EC) No 1225/2009 of 30 November 2009 on protection against dumped imports from countries not members of the European Community [1], and in particular Article 7 thereof,
ob upoštevanju Uredbe Sveta (ES) št. 1225/2009 z dne 30. novembra 2009 o zaščiti proti dampinškemu uvozu iz držav, ki niso članice Evropske skupnosti [1], in zlasti člena 7 Uredbe,
On 4 December 2010, the Commission announced, by a notice published in the Official Journal of the European Union [2], the initiation of an anti-dumping proceeding with regard to imports into the Union of vinyl acetate originating in the United States of America (hereinafter USA or the country concerned).
Dne 4. decembra 2010 je Komisija z obvestilom, objavljenim v Uradnem listu Evropske unije [2], objavila začetek protidampinškega postopka za uvoz vinilacetata s poreklom iz Združenih držav Amerike („ZDA“ ali „zadevna država“) v Unijo.
The proceeding was initiated as a result of a complaint lodged on 22 October 2010 by Ineos Oxide Ltd (‘the complainant’) representing a major proportion, in this case more than 25 % of the total Union industry production of vinyl acetate.
Postopek se je začel zaradi pritožbe, ki jo je 22. oktobra 2010 vložila družba Ineos Oxide Ltd („pritožnik“), ki predstavlja glavni delež, v tem primeru več kot 25 % celotne proizvodnje vinilacetata industrije Unije.
The Commission officially advised the complainant, other known producers in the Union, exporting producers in the country concerned, importers, traders, users, suppliers and associations known to be concerned, and the representatives of the United States of America of the initiation of the proceeding.
Komisija je pritožnika, druge znane proizvajalce v Uniji, proizvajalce izvoznike v zadevni državi, uvoznike, trgovce, uporabnike, dobavitelje in združenja, za katere je znano, da jih to zadeva, ter predstavnike ZDA uradno seznanila z začetkom postopka.
All interested parties, who so requested and showed that there were particular reasons why they should be heard were granted a hearing.
Vsem zainteresiranim stranem, ki so zahtevale zaslišanje in dokazale, da zanj obstajajo posebni razlogi, je bilo to odobreno.
The Commission sent questionnaires to the four known exporting producers in the country concerned.
Komisija je poslala vprašalnike štirim znanim proizvajalcem izvoznikom v zadevni državi.
Three such exporting producers provided a questionnaire response.
Trije od teh proizvajalcev izvoznikov so predložili izpolnjene vprašalnike.
The fourth exporting producer declined to cooperate with the investigation and was subsequently informed that it would be treated as a non-cooperating company in accordance with Article 18 of the basic Regulation.
Četrti proizvajalec izvoznik je odklonil sodelovanje v preiskavi in je bil posledično obveščen, da bo obravnavan kot nesodelujoča družba v skladu s členom 18 osnovne uredbe.
The Commission also sent questionnaires to the complainant and the other Union producer mentioned in the complaint.
Komisija je prav tako poslala vprašalnike pritožniku in drugemu proizvajalcu Unije, navedenemu v pritožbi.
In view of the apparent large number of unrelated importers which are potentially concerned by this investigation, sampling was envisaged in the notice of initiation in accordance with Article 17 of the basic Regulation.
Glede na pričakovano veliko število nepovezanih uvoznikov, ki jih ta preiskava lahko zadeva, je bilo v obvestilu o začetku v skladu s členom 17 osnovne uredbe predvideno vzorčenje.
In order to enable the Commission to decide whether sampling would be necessary and, if so, to select a sample, all unrelated importers were asked to make themselves known to the Commission and to provide information specified in the notice of initiation.
Da bi se Komisija lahko odločila, ali je vzorčenje potrebno, in da bi lahko v tem primeru izbrala vzorec, so bili vsi nepovezani uvozniki pozvani, da se javijo Komisiji in predložijo informacije, opredeljene v obvestilu o začetku.
However, given that only two importers came forward within the deadline set by the notice of initiation, it was decided that sampling was not necessary.
Vendar je bilo glede na to, da sta se v roku iz obvestila o začetku odzvala le dva uvoznika, sklenjeno, da vzorčenje ni potrebno.
Two importers in the Union duly replied to the questionnaire and a verification visit took place at the premises of one of them.
Dva uvoznika v Uniji sta ustrezno izpolnila vprašalnik, v prostorih enega od njiju pa je bil opravljen preveritveni obisk.
On the other hand, a number of interested parties made themselves known as users.
Po drugi strani so se številne zainteresirane strani razglasile za uporabnike.
A questionnaire specifically designed for users was sent to such parties.
Takim stranem je bila poslan poseben vprašalnik za uporabnike.
Twelve companies replied to the questionnaire and verification visits were carried out at the premises of two of them.
Vprašalnik je izpolnilo dvanajst družb, v prostorih dveh od njih pa so bili opravljeni preveritveni obiski.
Ineos Oxide Ltd, United Kingdom
Ineos Oxide Ltd, Združeno kraljestvo
Wacker Chemie AG, Germany
Wacker Chemie AG, Nemčija
Exporting producers in the country concerned
proizvajalci izvozniki v zadevni državi
Unrelated companies in the country concerned
nepovezane družbe v zadevni državi
Terminal, United States [name of party and exact location confidential]
Terminal, Združene države [ime strani in točna lokacija sta zaupna]
Related and unrelated companies in the Union
povezane in nepovezane družbe v Uniji
Celanese Chemicals Europe GmbH, Germany
Celanese Chemicals Europe GmbH, Nemčija
Lyondell Chemie Nederland B.V., Netherlands
Lyondell Chemie Nederland B.V., Nizozemska
Terminal, Union [name of party and exact location confidential]
Terminal, Unija [ime strani in točna lokacija sta zaupna]
Related companies neither in the Union, nor the United States of America
povezane družbe, ki niso ne iz Unije ne iz ZDA
Dow Europe GmbH, Switzerland
Dow Europe GmbH, Švica
Gantrade Ltd, United Kingdom
Gantrade Ltd, Združeno kraljestvo
Vinavil, Mapei, Italy
Vinavil, Mapei, Italija
Synthomer, United Kingdom
Synthomer, Združeno kraljestvo
The investigation of dumping and injury covered the period from 1 October 2009 to 30 September 2010 (the investigation period or IP).
Preiskava dampinga in škode je zajela obdobje od 1. oktobra 2009 do 30. septembra 2010 („obdobje preiskave“ ali „OP“).
The examination of trends relevant for the assessment of injury covered the period from 1 January 2007 to the end of the IP (the period considered).
Preučitev gibanj, pomembnih za oceno škode, je zajela obdobje od 1. januarja 2007 do konca OP („obravnavano obdobje“).
The product concerned is defined as vinyl acetate originating in the United States of America currently falling within CN code 29153200.
Zadevni izdelek je opredeljen kot vinilacetat s poreklom iz Združenih držav Amerike, ki se trenutno uvršča pod oznako KN 29153200.
Vinyl acetate (hereinafter VAM or the product concerned) is a commodity chemical derived from acetic acid.
Vinilacetat („VAM“ ali „zadevni izdelek“) je kemični proizvod, ki je pridobljen iz ocetne kisline.
Vinyl acetate has a wide variety of applications.
Vinilacetat se uporablja za številne namene.
The majority of vinyl acetate produced is used as an input into two downstream products: polyvinyl acetate and polyvinyl alcohol.
Glavni delež proizvedenega vinilacetata se uporablja kot vložek v dva izdelka s konca proizvodne verige: polivinil acetat in polivinil alkohol.
These downstream products are an important polymer in the various industries.
Ta izdelka s konca proizvodne verige sta pomembna polimera v različnih industrijah.
Vinyl acetate polymers are commonly used in the production of paints, adhesives, coatings and textile finishes.
Polimeri vinilacetata se pogosto uporabljajo pri proizvodnji barv, lepil, premazov in apreturi tekstila.
The investigation revealed that there is only one type of the product concerned.
Preiskava je pokazala, da obstaja le ena vrsta zadevnega izdelka.
The investigation showed that vinyl acetate produced and sold in the Union by the Union industry and the vinyl acetate produced in the country concerned and exported to the Union had the same basic physical, chemical and technical characteristics and uses.
Preiskava je pokazala, da imata vinilacetat, ki ga v Uniji proizvaja in prodaja industrija Unije, in vinilacetat, proizveden v zadevni državi in izvožen v Unijo, enake osnovne fizikalne, kemične in tehnične lastnosti ter uporabe.
Therefore, these products are provisionally considered to be alike within the meaning of Article 1(4) of the basic Regulation.
Zato se začasno šteje, da sta ta izdelka podobna v skladu s členom 1(4) osnovne uredbe.
For the determination of normal value, it was first established that domestic sales of the like product to independent customers of the respective exporting producers in the country concerned were representative, i.e. whether the total volume of such sales represented at least 5 % of its total export sales volume of the product concerned to the Union, in accordance with Article 2(2) of the basic Regulation.
Za določitev normalne vrednosti je bilo v skladu s členom 2(2) osnovne uredbe najprej ugotovljeno, da je bila domača prodaja podobnega izdelka neodvisnim strankam zadevnih proizvajalcev izvoznikov v zadevni državi reprezentativna, t.j. da je obseg takšne prodaje predstavljal vsaj 5 % celotnega obsega izvoza zadevnega izdelka v Unijo.
The Commission subsequently examined whether the domestic sales of each exporting producer could be considered as having been made in the ordinary course of trade pursuant to Article 2(4) of the basic Regulation.
Komisija je posledično preučila, ali se domača prodaja vsakega od proizvajalcev izvoznikov lahko šteje kot prodaja v običajnem poteku trgovine v skladu s členom 2(4) osnovne uredbe.
This was done by establishing the proportion of profitable domestic sales to independent customers during the IP.
To je bilo opravljeno tako, da je bil ugotovljen delež dobičkonosne domače prodaje neodvisnim strankam v OP.
Domestic sales transactions were considered profitable where the unit price was equal to or above the cost of production.
Domače prodajne transakcije so se štele za dobičkonosne, če je bila cena za enoto enaka ali višja od proizvodnih stroškov.
Cost of production on the domestic market during the IP was therefore determined.
Zato so bili določeni proizvodni stroški na notranjem trgu v OP.
In the case where more than 80 % by volume of sales on the domestic market were above cost and the weighted average sales price was equal to or higher than the weighted average production cost, normal value was calculated as the weighted average of all domestic sales prices, irrespective of whether they were profitable or not.
V primerih, kadar je bilo več kot 80 % obsega prodaje na domačem trgu nad stroški in je bila tehtana povprečna prodajna cena enaka tehtanim povprečnim proizvodnim stroškom ali višja, je bila normalna vrednost izračunana kot tehtano povprečje vseh domačih prodajnih cen ne glede na to, ali je bila prodaja dobičkonosna ali ne.
However, where the volume of profitable sales represented 80 % or less of the total sales volume, or where the weighted average sales price was below the weighted average production cost, normal value was on the weighted average price of only the profitable domestic sales.
Kadar je obseg dobičkonosne prodaje predstavljal 80 % ali manj celotnega obsega prodaje, ali kadar je bila tehtana povprečna prodajna cena pod tehtanimi povprečnimi proizvodnimi stroški, je normalna vrednost temeljila na tehtani povprečni ceni izključno dobičkonosne domače prodaje.
The investigation revealed that vinyl acetate was exported from the country concerned to the Union either (i) through related trading companies located in the Union; or (ii) for one exporting producer, through a related trading company outside the Union.
Preiskava je pokazala, da se je vinilacetat izvažal iz zadevne države v Unijo ali (i) prek povezanih trgovskih družb znotraj Unije ali (ii) za enega proizvajalca izvoznika prek povezane trgovske družbe zunaj Unije.
In both cases, the export prices were established on the basis of the resale prices to the first independent customers in the Union, pursuant to Article 2(9) of the basic Regulation, duly adjusted for all costs incurred between importation and resale, and profits.
V obeh primerih so bile izvozne cene v skladu s členom 2(9) osnovne uredbe določene na podlagi cen pri nadaljnji prodaji prvi neodvisni stranki v Uniji, ustrezno prilagojenimi za vse stroške, nastale med uvozom in nadaljnjo prodajo, ter dobičke.
The normal value and the export price of the respective exporting producers were compared on an ex works basis.
Normalna vrednost in izvozna cena zadevnih proizvajalcev izvoznikov sta bili primerjani na podlagi franko tovarna.